Results 241 to 250 of about 316,567 (264)

Type I interferon and type I interferon induced biomarkers in dermatomyositis: A systematic review

Journal of the European Academy of Dermatology and Venereology
Ryan S. Q. Geng, Samiha Mohsen, Kaitlyn Ramsay, Edgar Akuffo‐Addo, Richie Jeremian, Ernest Choy, Vincent Piguet   +6 more
openaire   +2 more sources

Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment

Cancer Cell, 2017
Costas Koumenis, Priya Chatterji, J Alan   +2 more
exaly  

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Lancet, The, 1998
Thierry Poynard, Vincent Bain, Gaetano Ideo   +2 more
exaly  

Interferons Type I

2011
openaire   +1 more source

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)

Lancet, The, 2002
Angelo Ghezzi, Mauro Bergui, Luca Durelli   +2 more
exaly  

Type I Interferon

2017
openaire   +1 more source

Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

Lancet, The, 1998
Anders Sönnerborg, Ola Weiland, Olle Reichard   +2 more
exaly  

Type I Interferon

2008
openaire   +1 more source

Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.

Journal of Experimental Medicine, 1984
Robert Schreiber
exaly  

Human interferon-epsilon: a type I interferon

1999
CHEN JIAN, GODOWSKI PAUL, WOOD WILLIAM I, ZHANG DONG-XIAO   +3 more
openaire   +2 more sources